title: Successful treatment with rituximab of one patient with CANOMAD neuropathy.
abstract: We report a successful treatment with rituximab in a patient with CANOMAD neuropathy resistant to previous therapy. The titers of anti-disialosyl antibodies were decreased 3 months after the beginning of the treatment and the sensory ataxia clearly improved after 9 months of therapy.
authors: Emilien
authors: E
authors: Delmont
authors: P Y
authors: PY
authors: Jeandel
authors: A M
authors: AM
authors: Hubert
authors: L
authors: L
authors: Marcq
authors: J
authors: J
authors: Boucraut
authors: C
authors: C
authors: Desnuelle
mesh_terms: D000368:Aged; D000744:Anemia, Hemolytic, Autoimmune / Q000150:complications / Q000188:drug therapy*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D000954:Antigens, Surface / Q000276:immunology; D005260:Female; D006801:Humans; D007075:Immunoglobulin M / Q000097:blood; D007155:Immunologic Factors / Q000627:therapeutic use*; D009844:Oligosaccharides / Q000276:immunology; D009886:Ophthalmoplegia / Q000150:complications / Q000188:drug therapy*; D011129:Polyradiculoneuropathy / Q000150:complications / Q000188:drug therapy*; D000069283:Rituximab
chemical_list: D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000954:Antigens, Surface; D007075:Immunoglobulin M; D007155:Immunologic Factors; D009844:Oligosaccharides; C108031:disialosyl-T antigen, human; D000069283:Rituximab